Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia

A bionic pancreas system has proven better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, in a clinical trial.

(via WSJ)

ADVERTISEMENT

ADVERTISEMENT
Just in:
Lai & Turner Law Firm PLLC Welcomes Eric Strocen as Director of Family Law Division // ZUHYX Exchange: Embracing Social Responsibility for a Sustainable Future // Octa crypto snapshot: investors behavior predictions after Bitcoin halving // Cairo Recognizes Arab World’s Creative Luminaries at Award Ceremony // Astana International Exchange Connects with Regional Markets Through Tabadul Hub // Leading with Compliance, ZUHYX Earns the Canadian MSB License // Quality HealthCare Partners with eHealth to Enhance Patient Treatment Efficiency // New Dynamics in Cryptocurrency Security: ZUHYX Builds the Strongest Fund Protection System // Abu Dhabi Secures US$5 Billion in Fresh Funding // Empty Promises Haunt DAO Maker Hack Victims After Three Years // Prince Holding Group’s Chen Zhi Scholarship Clinches Silver Stevie for CSR Excellence at Asia-Pacific Stevie Awards // Telecom Giant Du Eyes Crypto Integration for FinTech Platform // Congress in firefighting mode amid row over Pitroda remarks // Hong Kong Unveils April 30 Launch for Landmark Crypto ETFs // Andertoons by Mark Anderson for Thu, 25 Apr 2024 // CBN Targets User Accounts // Election Commission Has A Dismal Record On Acting Against Modi’s Breaches Of Poll Code // Cobb’s Game-Changer: Introducing One-Stop Event Transport Management Solution // Lee Chong Wei Shows Up On Chinese Hot cultural Talk Show “SHEDE Wisdom Talents”, Talking About “Crossing The Hill” // Dubai Gears Up for Second FinTech Summit as Funding Surges //